January 28, 2026 at 6:00 PM - Regular Meeting
| Agenda |
|---|
|
I. CALL TO ORDER
|
|
II. ROLL CALL
|
|
III. MOTION TO ADJOURN TO CLOSED SESSION
|
|
IV. CLOSED SESSION AGENDA
|
|
IV.A. The appointment, employment, compensation, discipline, performance or dismissal of specific employees of the School District or legal counsel for the School District, including hearing testimony on a complaint lodged against an employee of the public body or against legal counsel for the public body to determine its validity, 5 ILCS 120/2(c) (1).
|
|
IV.B. Collective negotiating matters between the public body and its employees or their representatives, or deliberations concerning salary schedules for one or more classes of employees. 5 ILCS 120/2(c)(2).
|
|
IV.C. Security procedures, school building safety and security, and the use of personnel and equipment to respond to an actual, a threatened, or a reasonably potential danger to the safety of employees, students, staff, the public, or public property. 5 ILCS 120/2(c)(8).
|
|
IV.D. Student disciplinary cases, 5 ILCS 120/2 (c) (9).
|
|
IV.E. The placement of individual students in special education programs and other matters relating to individual students. 5 ILCS 120/2 (c) (10).
|
|
IV.F. Litigation, 5 ILCS 120/2 (c) (11).
|
|
IV.G. Discussion of minutes of meetings lawfully closed under the Open Meetings Act, whether for purposes of approval by the body of the minutes or semi-annual review of the minutes as mandated by Section 2.06. 5 ILCS 120/2(c)(21).
|
|
V. MOTION TO ADJOURN CLOSED SESSION
|
|
VI. MOTION TO RECONVENE OPEN SESSION
|
|
VII. PLEDGE OF ALLEGIANCE
|
|
VIII. ROLL CALL
|
|
IX. SUPERINTENDENT'S REPORT
|
|
IX.A. School Spotlight: Hiawatha Elementary
|
|
IX.B. Funding Advocacy
|
|
IX.C. 2026-2027 School Calendar
|
|
IX.D. FOIA
|
|
IX.E. Dashboard
|
|
IX.F. Financial Report
|
|
X. PRESIDENT'S REPORT
|
|
X.A. Finance
|
|
X.B. Policy
|
|
X.C. Legislative Report
|
|
X.D. Correspondence
|
|
XI. PUBLIC COMMENTS: Individuals appearing before the Board are expected to follow the guidelines outlined in Board Policy 2:230.
|
|
XII. ACTION ITEMS - Consent Agenda - Items may be removed from the consent agenda on the request of any one member. Items not removed may be adopted by general consent without debate. Removed items may be taken up either immediately after the consent agenda or placed later on the agenda at the discretion of the Board.
|
|
XII.A. Minutes
|
|
XII.A.1. Approve minutes from 12.17.25 regular meeting.
|
|
XII.A.2. Approve the confidentiality of closed session minutes and audio recording from July through December 2025.
|
|
XII.A.3. Approve the destruction of verbatim recordings of closed session meetings older than 18 months, per the Open Meetings Act (OMA). All closed meeting recordings prior to and including June 2024 will be destroyed.
|
|
XII.B. Bills and Payroll
|
|
XII.B.1. Approve payment of bills totaling $2.610,912.06
|
|
XII.B.2. Confirm payment of the payroll for 12.20.25 in the amount of $1,465,708.84 and 1.15.26 in the amount of $1,432,843,98. Authorize the preparation and release of payroll dated 1.30.26 and 2.13.26.
|
|
XII.C. Approve policies for adoption: 5:190 Teacher Qualifications; 5:200 Terms and Conditions of Employment and Dismissal; 5:220 Substitute Teachers; 5:280 Duties and Qualifications; 5:300 Schedules and Employment Year; 6:20 School Year Calendar and Day; 6:40 Curriculum Development; 6:130 Program for the Gifted; 6:160 English Learners; 6:210 Instructional Materials.
|
|
XII.D. Approve the Suburban School Cooperative Insurance Pool (SSCIP) Liability Insurance Renewal for 2026 at a total cost of $347,841.00 which includes Cyber Insurance.
|
|
XII.E. Approve the 2026-2027 Calendar.
|
|
XII.F. Approve Personnel Report
A. Employment B. Resignations C. Retirements D. Leaves of Absence E. Dismissals F. Last Chance Agreements G. Change of Status H. Notice to Remedy |
|
XIII. PUBLIC COMMENTS: Individuals appearing before the Board are expected to follow the guidelines outlined in Board Policy 2:230.
|
|
XIV. BOARD MEMBER COMMENTS
|
|
XV. ADJOURNMENT
|